6-Thioguanine nucleotide levels are associated with infliximab but not adalimumab levels in inflammatory bowel disease patients on combination therapy.
Yu N, Lee T, Tassone D, Vogrin S, Phan S, Wu DM, Zhang J, Wang L, Tjahyadi J, Dutt K, Liou H, Basnayake C, Wright E, Niewiadomski O, Lust M, Schulberg J, Kamm MA, Connell W, Thompson AJ, Hilmi I, Raja Ali RA, Wei SC, De Cruz P, Friedman AB, Moore GT, Van Langenberg D, Ding NS.
Yu N, et al. Among authors: basnayake c.
Intern Med J. 2024 Nov;54(11):1856-1866. doi: 10.1111/imj.16504. Epub 2024 Sep 5.
Intern Med J. 2024.
PMID: 39234975